2022 Medtech & Healthtech Investment and Exit Trends

Galen Data Medical Device Innovation Webinar Series Presents:   

2022 MEDTECH AND HEALTHTECH INVESTMENT AND EXIT TRENDS   

Inflation, global geopolitical factors and interest rate hikes all contributed to a tumultuous year in the public and private markets. Nevertheless, after a record year in 2021, venture fundraising continued to surge for healthtech and medical device companies in 2022.   Join Jon Norris, Managing Director, Healthcare at SVB, Raysa Bousleiman, Senior Market Researcher, and Annie Scolamieri, Market Researcher, as they discuss the latest medtech and healthtech trends and predictions for 2023.  

Key Takeaways:  

👉 How did medtech companies fare in terms of fundraising in 2022 (compared to venture overall)?      

👉 Have there been any shifts between the stage and types of companies that are being funded?  

👉 How have the IPO and M&A markets been for healthtech companies looking to exit?  

👉 What can the industry expect to see going into 2023?   

About SVB: SVB is the financial partner of the innovation economy, helping individuals, investors and the world’s most innovative companies achieve their ambitious goals. SVB’s businesses - Silicon Valley Bank, SVB Capital, SVB Private and SVB Securities - together offer the services that dynamic and fast-growing clients require as they grow, including commercial banking, venture investing, wealth planning and investment banking. Headquartered in Santa Clara, California, SVB operates in centers of innovation around the world. Learn more at svb.com/global.